Precipio (NASDAQ:PRPO) Share Price Crosses Above 200-Day Moving Average – Should You Sell?

Precipio, Inc. (NASDAQ:PRPO) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.30 and traded as high as $10.74. Precipio shares last traded at $10.14, with a volume of 77,637 shares changing hands.

Precipio Stock Up 5.2 %

The company has a market capitalization of $15.03 million, a price-to-earnings ratio of -5.54 and a beta of 1.42. The business’s 50-day moving average is $6.42 and its 200-day moving average is $6.31. The company has a quick ratio of 0.60, a current ratio of 0.73 and a debt-to-equity ratio of 0.02.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Precipio stock. Renaissance Technologies LLC purchased a new position in shares of Precipio, Inc. (NASDAQ:PRPO) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 10,100 shares of the biotechnology company’s stock, valued at approximately $56,000. Renaissance Technologies LLC owned about 0.68% of Precipio as of its most recent SEC filing. 10.45% of the stock is currently owned by hedge funds and other institutional investors.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.